Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 -0.26M
March 31, 2023 -0.582M
December 31, 2022 -0.706M
September 30, 2022 -0.861M
June 30, 2022 -0.865M
March 31, 2022 -0.671M
December 31, 2021 -0.693M
September 30, 2021 -0.538M
June 30, 2021 -0.486M
March 31, 2021 -0.393M
December 31, 2020 -0.374M
September 30, 2020 -0.272M
June 30, 2020 -0.368M
March 31, 2020 -0.38M
December 31, 2019 -0.313M
September 30, 2019 -0.329M
June 30, 2019 -0.305M
March 31, 2019 -0.261M
December 31, 2018 -0.204M
September 30, 2018 -0.169M
June 30, 2018 -0.275M
March 31, 2018 -0.389M
December 31, 2017 -1.095M
September 30, 2017 -1.685M
June 30, 2017 -2.024M
Date Value
March 31, 2017 -2.539M
December 31, 2016 -2.737M
September 30, 2016 -3.152M
June 30, 2016 -3.694M
March 31, 2016 -4.344M
December 31, 2015 -4.637M
September 30, 2015 -4.867M
June 30, 2015 -4.957M
March 31, 2015 -5.237M
December 31, 2014 -5.048M
September 30, 2014 -5.083M
June 30, 2014 -5.131M
March 31, 2014 -4.715M
December 31, 2013 -4.715M
September 30, 2013 -4.491M
June 30, 2013 -4.672M
March 31, 2013 -4.495M
December 31, 2012 -4.528M
September 30, 2012 -4.598M
June 30, 2012 -4.396M
March 31, 2012 -4.454M
December 31, 2011 -3.744M
September 30, 2011 -3.458M
June 30, 2011 -2.797M
March 31, 2011 -2.713M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 145.62M
Alnylam Pharmaceuticals, Inc. 793.94M
Savara, Inc. -110.66M
Vericel Corp. 61.66M
Biogen, Inc. 2.49B